Clinical trial
A Phase 1 Study of Cusatuzumab Plus Azacitidine in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
NCT04241549 is registered in ClinicalTrials.gov with OncoVerity, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of Cusatuzumab Plus Azacitidine in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
- Lead sponsor
- OncoVerity, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 25, 2020
- Completion date
- July 19, 2021
- Enrollment
- 6 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.